Can a virtual promotora get more hispanic women screened for cervical cancer?
NCT ID NCT06741241
First seen Sep 11, 2026 · Last updated Sep 11, 2026
Summary
Researchers at Florida A&M University are testing whether a virtual educational session led by a lay health advisor, called a promotora, helps Hispanic women who are behind on cervical cancer screening get tested. The trial enrolls about 160 Hispanic women ages 21 to 65 who have never been screened or whose last Pap test was three or more years ago. Participants are assigned by group to either the cervical cancer education session or a nutrition education session. The main measure is whether participants complete cervical cancer screening within six months.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- a virtual educational session delivered by a lay health advisor, called a promotora
- What this could lead to
- If it works, this could offer a low-cost, culturally tailored way to help more Hispanic women get screened for cervical cancer.
- What could go wrong
- The trial is small and relies on self-reported screening plus chart review, so results may not hold up in larger or different groups. A single education session may not overcome cost, transport, or language barriers.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
About 170 people
The number the study aims to enrol. It can still change while the study runs.
- Started
-
Sep 2026
- Expected to finish
-
Sep 2029
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
21 to 65 years
- Sex
-
Female participants only
- Healthy volunteers
-
Accepted
You do not need to have the condition being studied to take part.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: 1. between the age of 21 and 65 years 2. identify as Hispanic 3. not up-to-date with cervical cancer screening \[never screened or last Pap test ≥ 3 years - based on U.S. Preventive Services Task Force guidelines\] 4. have no history of cervical cancer 5. have not had a hysterectomy. Exclusion Criteria: 1. under the age of 21 or over the age of 65 years 2. do not identify as Hispanic 3. up-to-date with cervical cancer screening \[last Pap test \< 3 years - based on U.S. Preventive Services Task Force guidelines\] 4. history of cervical cancer 5. have had a hysterectomy.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Cervical cancer screening are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The places running it
1 site. The list below names each one and where it is.
-
The official record
ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
Contacts and locations
Locations
-
Florida A&M University
RECRUITINGTallahassee, Florida, 32307, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Cervical smear DNA may reveal ovarian cancer years before symptoms
- A digital coach may guide patients through cervical cancer prevention
- Self-swabs could boost cervical cancer screening in kazakhstan
- Self-sampling for cervical cancer screening could make testing easier and more accessible
- Self-Sampling could boost cervical cancer screening for women with HIV
- ERs may soon offer At-Home HPV tests to reach women who skip screenings